CorMedix Inc.

CRMD
$7.62 (- $0.09 - 1.23%)
Last updated: 2026-06-26 18:32 UTC
CRMD Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS21900C3088
CUSIP21900C308
Market Price7.62
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E Ratio5.47
EPS2.21
Market Cap$952.6M
Book Value4.78
Price to Book2.532
Beta1.32
52w High17.43
52w Low5.6
Next Earnings DateN/A

CorMedix Inc. trades under ticker CRMD on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US21900C3088, CUSIP 21900C308. Also searched as CorMedix.

Related researchCRMD stock priceCRMD share price21900C308CorMedix stockCorMedix share price
About the Company
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Price History